November 4, 2021
Hidefumi Date, chief financial officer at Mitsubishi Chemical Holdings, said on November 2 that the company will consider the domestic manufacturing of MT-2766, a COVID-19 vaccine candidate being developed by Mitsubishi Tanabe Pharma’s Canadian subsidiary Medicago. Mr Date made the...read more